Sinclair Pharma Plc (SPH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
November 2018
46
About the Report
About the Report
Summary
Sinclair Pharma plc (Sinclair), formerly Sinclair IS Pharma plc, is an aesthetics company, which strives to provide dermatological solutions. The company develops, manufactures and distributes dermatological products for facial aesthetics, particularly for facial rejuvenation, through collagen stimulation. It offers complementary aesthetics technologies; and longer duration, natural looking and minimally-invasive treatments. It also offers dermal fillers for folds and lines. Some of Sinclair's major products include Silhouette Soft; Ellanse; Perfectha and Sculptra. It has direct sales and marketing presence in five major European countries and Brazil. It also has multi-product and multi-country distribution partnerships with several companies. Sinclair is headquartered in London, the UK.
Sinclair Pharma Plc (SPH)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Sinclair Pharma Plc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sinclair Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sinclair Pharma Plc, Medical Devices Deals, 2012 to YTD 2018 10
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deal Details 12
Private Equity 12
Huadong Medicine to Acquire Sinclair Pharma 12
Partnerships 14
Sinclair IS Pharma Enters Into Co-Promotion Agreement With Galderma For Kelo-cote 14
Licensing Agreements 15
Sinclair IS Pharma Enters Into Licensing Agreement With Hikma Pharma For Flammacerium 15
Sinclair IS Pharma Enters Into Licensing Agreement With Menarini Group For Three Products 16
Sinclair IS Pharma Enters Into Agreement With Biocodex For Dermatology Portfolio 17
Quintiles Enters Into Licensing Agreement With Sinclair IS Pharma 18
Equity Offering 19
Sinclair IS Pharma Announces Private Placement Of Shares For USD 15 Million 19
Asset Transactions 20
Alliance Pharma Acquires Healthcare Products Business from Sinclair IS Pharma for USD198.4 Million 20
Bailleul Biorga And Hexim Pharma Acquire Non-Core Products From Sinclair IS Pharma For USD 1.8 Million 21
Acquisition 22
Sinclair IS Pharma to Sell Itself 22
Sinclair Is Pharma Acquires Obvieline Labs From Pharmavital 23
Sinclair Pharma Plc-Key Competitors 24
Sinclair Pharma Plc-Key Employees 25
Sinclair Pharma Plc-Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 28
Financial Announcements 28
Sep 27, 2018: Sinclair Pharma: Interim results for the six months ended 30 June 2018 28
Apr 30, 2018: Sinclair Pharma: Preliminary results for 12 months ended 31 December 2017 32
Sep 19, 2017: Sinclair Pharma: Interim Results 35
Mar 21, 2017: Sinclair Pharma Announces Preliminary results for the 12 and 18 months ended 31 December 2016 40
Jan 17, 2017: Sinclair Pharma Announces Pre-Close Trading Update 41
Corporate Communications 42
Mar 30, 2017: Sinclair Pharma: Additional listing 42
Other Significant Developments 43
Jul 05, 2018: Sinclair Pharma: Trading Update for the 6 months to 30 June 2018 43
Jul 11, 2017: Sinclair Pharma: Trading Update for the 6 months to 30 June 2017 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46
List of Figure
List of Figures
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Sinclair Pharma Plc, Medical Devices Deals, 2012 to YTD 2018 10
List of Table
List of Tables
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Sinclair Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Sinclair Pharma Plc, Deals By Therapy Area, 2012 to YTD 2018 8
Sinclair Pharma Plc, Medical Devices Deals, 2012 to YTD 2018 10
Sinclair Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Huadong Medicine to Acquire Sinclair Pharma 12
Sinclair IS Pharma Enters Into Co-Promotion Agreement With Galderma For Kelo-cote 14
Sinclair IS Pharma Enters Into Licensing Agreement With Hikma Pharma For Flammacerium 15
Sinclair IS Pharma Enters Into Licensing Agreement With Menarini Group For Three Products 16
Sinclair IS Pharma Enters Into Agreement With Biocodex For Dermatology Portfolio 17
Quintiles Enters Into Licensing Agreement With Sinclair IS Pharma 18
Sinclair IS Pharma Announces Private Placement Of Shares For USD 15 Million 19
Alliance Pharma Acquires Healthcare Products Business from Sinclair IS Pharma for USD198.4 Million 20
Bailleul Biorga And Hexim Pharma Acquire Non-Core Products From Sinclair IS Pharma For USD 1.8 Million 21
Sinclair IS Pharma to Sell Itself 22
Sinclair Is Pharma Acquires Obvieline Labs From Pharmavital 23
Sinclair Pharma Plc, Key Competitors 24
Sinclair Pharma Plc, Key Employees 25
Sinclair Pharma Plc, Other Locations 26
Sinclair Pharma Plc, Subsidiaries 26
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.